NDC 63323-495-04 - Xylocaine MPF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-495
- Requested NDC
- 63323-495-04
- Package NDCs from labels
- 63323-495-41, 63323-495-26, 63323-495-09, 63323-495-27, 63323-495-04, 63323-495-07
- Manufacturer
- Sportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEM
- Effective date
- 2026-07-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine MPF - Sportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEM | Sportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEM | 2026-07-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE- MPF (LIDOCAINE HCl ) - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2018-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-495-04 | XylocaineMPF | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 13 | |
| 63323-495-07 | XylocaineMPF | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 13 | |
| 63323-495-09 | XylocaineMPF | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 13 | |
| 63323-495-27 | XylocaineMPF | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 13 | |
| 63323-495-26 | XylocaineMPF | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 7 | |
| 63323-495-41 | XylocaineMPF | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-495 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 4 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-495 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-495-04 | ML - Milliliter | 63323-495 | d0d889ee-8d0d-4b4b-8dc4-1d08d7aa1a41 | 1 | 2020-03-10 |
| 63323-495-07 | ML - Milliliter | 63323-495 | 45547802-d87e-4057-bfda-bebd10558002 | 1 | 2012-07-24 |
| 63323-495-09 | ML - Milliliter | 63323-495 | 1fbc9b28-5732-408b-a1a2-0e6a181a0e86 | 1 | 2020-03-10 |
| 63323-495-26 | ML - Milliliter | 63323-495 | b3ea65e0-9341-428d-8e1d-1f11c3581b3e | 1 | 2016-06-14 |
| 63323-495-27 | ML - Milliliter | 63323-495 | 46c9de9e-011a-43e9-8adb-4779dae79603 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2026-10-28 | Warnings | 451W47IQ8X |
| Articaine HCL and Epinephrine | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Aira LLC | 905cade1-9b37-486a-ac12-21f3262ab4e2 | 2026-10-27 | Warnings, Adverse reactions | 30Q7KI53AK |
| Normal Salt | SODIUM CHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | f3f09817-8a38-4aa1-956b-69d9cf695074 | 2026-10-26 | Warnings | 451W47IQ8X |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | 3b0282a6-9bfd-4052-b69c-2c68d488d009 | 2026-10-22 | Warnings, Adverse reactions | 1010033 |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-10-19 | Warnings, Adverse reactions | 1737757 1737343 1010900 1010033 1737636 1737763 1010671 1737562 1737566 1737568 |
| epinephrine | EPINEPHRINE | Baxter Healthcare Corporation | 60efd409-3555-4182-a68d-1cd7bc0d1bfc | 2026-10-19 | Warnings, Adverse reactions | 30Q7KI53AK |
| AQUACETIC-30 | CLEANING SOLUTION FOR HEMODIALYSIS MACHINES | Aqua Medica, S.A. de C.V. | 040775ab-41bd-cd36-e063-6394a90a08aa | 2026-10-16 | Warnings | 2968PHW8QP |
| CITRACID-50 | DESINFECTANT SOLUTION FOR HEMODIALYSIS MACHINE | Aqua Medica, S.A. de C.V. | 040713e7-67cd-8eb0-e063-6394a90aa2a9 | 2026-10-16 | Warnings | 2968PHW8QP |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 2968PHW8QP |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Safco Dental Supply Co | 6721c3ab-c37f-4504-aebc-0103c56ed567 | 2026-10-08 | Warnings, Adverse reactions | 30Q7KI53AK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.